Oriola Oyj (LON:0NES)

Market Cap	168.57M
Revenue (ttm)	1.47B
Net Income (ttm)	-19.41M
Shares Out	n/a
EPS (ttm)	-0.11
PE Ratio	n/a
Forward PE	20.90
Dividend	0.06 (5.62%)
Ex-Dividend Date	Apr 3, 2025

Volume	11,367
Average Volume	7,308
Open	1.058
Previous Close	1.054
Day's Range	1.046 - 1.058
52-Week Range	0.877 - 1.158
Beta	0.59
RSI	52.70
Earnings Date	Jul 18, 2025

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1907
• Employees: 934
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial numbers in EUR